0001209191-20-042292.txt : 20200713
0001209191-20-042292.hdr.sgml : 20200713
20200713165020
ACCESSION NUMBER: 0001209191-20-042292
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200713
FILED AS OF DATE: 20200713
DATE AS OF CHANGE: 20200713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Branning Todd P.
CENTRAL INDEX KEY: 0001765274
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39094
FILM NUMBER: 201025648
MAIL ADDRESS:
STREET 1: C/O AMNEAL PHARMACEUTICLAS, INC.
STREET 2: 400 CROSSING BOULEVARD
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phathom Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001783183
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824151574
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CAMPUS DRIVE,
STREET 2: SUITE 102
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: (877) 742-8466
MAIL ADDRESS:
STREET 1: 100 CAMPUS DRIVE,
STREET 2: SUITE 102
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-07-13
0
0001783183
Phathom Pharmaceuticals, Inc.
PHAT
0001765274
Branning Todd P.
C/O PHATHOM PHARMACEUTICALS, INC.
100 CAMPUS DRIVE, SUITE 102
FLORHAM PARK
NJ
07932
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
29.43
2020-07-13
4
A
0
85000
0.00
A
2030-07-12
Common Stock
85000
85000
D
The option will vest with respect to one-fourth of the shares of common stock on July 13, 2021, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the applicable vesting dates.
/s/ Larry Miller, Attorney-in-Fact for Todd Branning
2020-07-13